SecBot SecBot
SECBOTREPLAY Home › Report › SYRE

SYRE · CEO and CMO sold a combined $1.85M in open-market sales at ~$69.50,…

Spyre Therapeutics, Inc. · CLUSTER filed Apr 30, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Apr 30, 2026 at 20:00 ET

CEO and CMO sold a combined $1.85M in open-market sales at ~$69.50, representing 0.027% of Spyre's $6.9B market cap. The CMO also exercised and sold shares from a derivative grant, a routine cashless exercise pattern. The dollar amount is trivial relative to market cap, making this a routine cluster with no material directional signal.

  • CEO Turtle Cameron sold 5,300 shares for $369K on May 1, 2026
  • CMO Sloan Sheldon sold 21,306 shares for $1.48M on May 1, 2026
  • CMO also exercised 78,333 derivative shares at $27.46 ($2.15M) and 78,333 at $0 (non-cash award), these are non-cash events
  • Total open-market sales of $1.85M represent just 0.027% of $6.9B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access